Pertussis Antibody Concentrations in Infants Born Prematurely to Mothers Vaccinated in Pregnancy

Alison Kent1, Shamez N Ladhani2, Nick J Andrews3

  • 1Paediatric Infectious Diseases Research Group and Vaccine Institute, St George's, University of London, London, United Kingdom; alisonkent@doctors.org.uk.

Pediatrics
|June 4, 2016
PubMed

Insights

Maternal antenatal pertussis vaccination in early pregnancy boosts antibody levels in premature infants. This protection may wane after infant immunization but appears to offer initial benefits for vulnerable newborns.

Area of Science:

  • Immunology
  • Neonatal Care
  • Vaccinology

Background:

  • Maternal antenatal pertussis vaccination is recommended for neonatal pertussis prevention.
  • Its efficacy in protecting premature infants remains largely unknown.
  • This study investigated antibody responses in premature infants born to vaccinated mothers.

Purpose of the Study:

  • To determine if maternal antenatal pertussis vaccination enhances antibody concentrations in premature infants.
  • To compare antibody levels in premature infants of vaccinated versus unvaccinated mothers.

Main Methods:

  • Mothers received a combined tetanus, diphtheria, acellular pertussis, and inactivated polio vaccine.
  • Antibody concentrations (pertussis toxin, FHA, fimbriae) were measured in premature infants at 2, 5, and 12 months of age.
  • Infants were part of a randomized controlled trial for pneumococcal conjugate vaccine schedules.

Main Results:

  • Premature infants of vaccinated mothers had significantly higher antibody concentrations at 2 months for all measured pertussis antigens.
  • Earlier maternal vaccination correlated positively with higher immunoglobulin G concentrations at 2 months.
  • Infants of vaccinated mothers showed lower FHA antibody levels after primary immunization, which resolved by 12 months.

Conclusions:

  • Maternal vaccination in early third trimester may confer protection to premature infants.
  • Antenatal pertussis vaccination appears beneficial for premature infants' early antibody levels.
Abstract

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Vaccinations01:51

Vaccinations

Overview
53.3K
Diphtheria01:28

Diphtheria

Diphtheria is an acute, toxin-mediated infectious disease that primarily affects the upper respiratory tract. It is caused by Corynebacterium diphtheriae, a Gram-positive, pleomorphic rod that lacks spore-forming capability and exhibits a characteristic club-shaped morphology under microscopic examination. While C. diphtheriae can asymptomatically colonize mucosal surfaces, clinical disease manifests only when the bacterial strain is lysogenized by a specific β-corynephage. This phage...
16
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
4.5K
Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
7